Matrix metalloproteinases in reproductive endocrinology

Trends in Endocrinology and Metabolism

Volumn 15, Issue 2, 2004, Pages 47-49

  Shah, Bukhtiar H ^a   Catt, Kevin J ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GONADORELIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ENZYME ACTIVITY; GONADOTROPIN SECRETING CELL; HORMONE ACTION; HUMAN; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPRODUCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 1342287025     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2004.01.004     Document Type: Short Survey

References (17)

1. Seals D.F., Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17:2003;7-30.
2. Curry T.E. Jr, Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24:2003;428-465.
3. Prenzel N., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
4. Thomas W.G., et al. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90:2002;135-142.
5. Asakura M., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metallproteinase inhibitors as a new therapy. Nat. Med. 8:2002;35-40.
6. Yan Y., et al. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158:2002;221-226.
7. Shah B.H., Catt K.J. A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol. Sci. 24:2003;239-244.
8. Roelle S., et al. Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor trransactivation by gonadotropin-releasing hormone. J. Biol. Chem. 278:2003;47307-47318.
9. Krsmanovic L.Z., et al. Autocrine regulation of gonadotropin-releasing hormone secretion in cultured hypothalamic neurons. Endocrinology. 140:1999;1423-1431.
10. Stojilkovic S.S., Catt K.J. Novel aspects of GnRH-induced intracellular signaling and secretion in pituitary gonadotrophs. J. Neuroendocrinol. 7:1995;739-757.
11. Liu F., et al. GnTH activates ERK1/2 leading to the induction of c-fos and LHβ protein expression in LßT2 cells. Mol. Endocrinol. 16:2002;419-434.
12. Chou C., et al. Dose-dependent effects of gonadotropin releasing hormone on matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specific inhibitor of metalloproteinase-1 messenger ribonucleic acid levels in human decidual stromal cells in vitro. J. Clin. Endocrinol. Metab. 88:2003;680-688.
13. Shah B.H., et al. Roles of Src and EGF receptor transactivation in transient and sustained ERK1/2 responses to GnRH receptor activation. J. Biol. Chem. 278:2003;19118-19126.
14. Shah B.H., et al. Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation. J. Biol. Chem. 278:2003;2866-2875.
15. Grosse R., et al. Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone. J. Biol. Chem. 275:2000;12251-12260.
16. Shah B.H., et al. Neuropeptide-induced transactivation of a neuronal EGF receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor. J. Biol. Chem. 279:2004;414-420.
17. Moenter S.M., et al. Mechanisms underlying episodic gonadotropin- releasing hormone secretion. Front. Neuroendocrinol. 24:2003;79-93.